logo
  • Global Challenge
  • Our Approach
  • Partnering
  • Pipeline
  • Join Us
  • News & Events
  • Investors
    • Company Information
    • Board and Management
    • Advisors
    • Investor Alert
  • Publications
  • Contact

Infex webinar - broader pipeline and growth strategy

May 14, 2024
|In Breaking News, Events, Pipeline, Publications
|By admin

On 9th May 2024, Infex Therapeutics held a live webinar, to update on the company’s broader pipeline and growth strategy.

To view the webinar recording, please click on the link below:
Infex webinar – broader pipeline and growth strategy

  • Prev
  • All Stories
  • Next

Related News


Infex Therapeutics logo

Infex to present webinar on broader pipeline and growth strategy

Infex Therapeutics, a leading anti-infectives specialist, announces it will be holding a…

StickyBreaking News,Events,Pipeline,Press Releases

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Pa-positive NCFB patients experienced a significant reduction in annualised exacerbation…

Pipeline,Alderley Park,Events,Breaking News,Press Releases

Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026

Presentation will provide additional analysis from the Phase IIa study of RESP-X in…

Breaking News,Events,Pipeline,Press Releases

Infex Therapeutics logo

Infex Therapeutics written submission to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)

Events,Breaking News

Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa

Infex Therapeutics, a leading anti-infectives specialist, today announced positive…

Pipeline,Press Releases,Breaking News

Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections

Investment led by Jon Moulton supports progression of clinical and preclinical programmes…

Breaking News,Events,Press Releases

World AMR Awareness Week 2025

This World AMR Awareness Week, we're proud to be celebrating our collaboration with…

Events,Breaking News

Dr Pete Jackson and Prof Janet Hemingway

UK Government investment is vital to combat AMR

As the world wakes to the reality of the crisis posed by antimicrobial resistance (AMR),…

Press Releases,Breaking News

Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID

Memorandum of Understanding signed to investigate hospital-acquired drug-resistant…

Pipeline,Press Releases,Breaking News

Infex signs exclusive license agreement with Venus Remedies Ltd to advance MET-X through clinical development and commercialisation in India

Infex Therapeutics, a leading anti-infectives specialist, announces that it has signed an…

Pipeline,Press Releases,Breaking News

© Infex Therapeutics Ltd. All rights reserved.